Blog

Novartis to test new pricing model with heart failure drug

By Ben Hirschler BASEL, Switzerland (Reuters) – Novartis plans to test a novel pricing model with some customers when it launches its keenly awaited new heart failure drug Entresto, the Swiss company’s head of pharmaceuticals said on Tuesday. How the product should be priced, however, is a dilemma for Novartis, since the company wants to reach as many patients as possible and it knows it will be competing with very